A C-reactive protein level of 3.3 mg/L indicates high cardiovascular risk and warrants evaluation for sources of inflammation.
Risk Stratification
Your CRP of 3.3 mg/L places you in the high-risk category for cardiovascular disease. According to CDC/AHA guidelines, CRP levels are categorized as follows 1:
- Low risk: <1.0 mg/L
- Average risk: 1.0 to 3.0 mg/L
- High risk: >3.0 mg/L
Your value of 3.3 mg/L exceeds the 3.0 mg/L threshold, placing you at elevated cardiovascular risk compared to the general population.
Clinical Significance
This level indicates chronic low-grade inflammation, which is associated with increased risk of:
The prognostic value of CRP at this level is comparable to blood pressure or cholesterol in predicting cardiovascular events 2.
Important Considerations
Rule Out Acute Inflammation First
While 3.3 mg/L suggests chronic inflammation rather than acute infection, you should be evaluated for potential sources of inflammation 1. The guidelines specify that CRP levels ≥10 mg/L warrant investigation for active infection or acute inflammatory conditions, but your level is below this threshold.
Confirm the Result
Best practice requires obtaining two CRP measurements (optimally 2 weeks apart) and averaging the results to account for biological variability 1. A single measurement may not accurately reflect your baseline inflammatory state.
Other Inflammatory Conditions
Mildly elevated CRP (like yours) can occur with:
- Inflammatory bowel disease
- Rheumatoid arthritis
- Chronic alcoholism
- Obesity (strongest association with OR 3.78)
- Diabetes
- Metabolic syndrome 1, 4
Clinical Action
For primary prevention in patients with CRP >2 mg/L and LDL cholesterol <130 mg/dL, statin therapy reduces the rate of first cardiovascular events by 47% 2. This comes from the landmark JUPITER trial, which demonstrated significant mortality benefit in this population.
Risk Assessment Algorithm:
- Repeat CRP measurement in 2 weeks if metabolically stable
- Evaluate for modifiable risk factors: obesity (BMI ≥30), diabetes, hypertension, smoking, dyslipidemia
- Calculate global cardiovascular risk using algorithms that incorporate CRP (these outperform Framingham risk scores alone) 2
- Consider lifestyle interventions first: diet modification, exercise, smoking cessation 2
- Discuss statin therapy if other cardiovascular risk factors are present, particularly if LDL <130 mg/dL but CRP remains elevated
Common Pitfalls
- Don't ignore this value thinking it's "only slightly elevated" - the threshold of 3.0 mg/L is evidence-based for cardiovascular risk stratification
- Don't assume acute infection at this level - values of 3.3 mg/L typically reflect chronic inflammation, not acute illness (which usually produces CRP >10 mg/L)
- Don't use CRP in isolation - it adds prognostic information but should be integrated with traditional risk factors 1, 2
The attributable risk of elevated CRP to traditional cardiovascular risk factors is 78% in men and 67% in women 4, meaning most people with elevated CRP have identifiable modifiable risk factors that should be addressed.